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Abstract 
Background: Late stage of cancer at diagnosis is an important predictor of cancer mortality. In many areas world-
wide, cancer registry systems, available data and mapping technologies can provide information about late stage can-
cer by geographical regions, offering valuable opportunities to identify areas where further investigation and inter-
ventions are needed. The current study examined geographical variation in late stage breast cancer incidence across 
eight states in the United States with the objective to identify areas that might benefit from targeted interventions.
Methods: Data from the Surveillance Epidemiology and End Results Program on late stage breast cancer incidence 
was used as dependent variable in regression analysis and certain factors known to contribute to high rates of late 
stage cancer (socioeconomic characteristics, health insurance characteristics, and the availability and utilization of 
cancer screening) as covariates. Geographic information systems were used to map and highlight areas that have any 
combination of high late stage breast cancer incidence and significantly associated risk factors.
Results: The differences in mean rates of late stage breast cancer between eight states considered in this analysis 
are statistically significant. Factors that have statistically negative association with late stage breast cancer incidence 
across the eight states include: density of mammography facilities, percent population with Bachelor’s degree and 
English literacy while percent black population has statistically significant positive association with late stage breast 
cancer incidence.
Conclusions: This study describes geographic disparities in late stage breast cancer incidence and identifies areas 
that might benefit from targeted interventions. The results suggest that in the eight US states examined, higher rates 
of late stage breast cancer are more common in areas with predominantly black population, where English literacy, 
percentage of population with college degree and screening availability are low. The approach described in this 
work may be utilized both within and outside US, wherever cancer registry systems and technologies offer the same 
opportunity to identify places where further investigation and interventions for reducing cancer burden are needed.
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Background
Breast cancer is the top cancer in women worldwide and 
is increasing particularly in developing countries where 
the majority of cases are diagnosed in late stages [1]. 
Late stage of cancer at diagnosis is an important pre-
dictor of cancer mortality. Understanding geographic 
disparities in late stage of breast cancer at diagnosis 
is critical for cancer control activities. In many areas 
worldwide, cancer registry systems, available data and 
mapping technologies can provide information about 
late stage cancer by geographic regions, offering valua-
ble opportunities to identify places where further inves-
tigation and interventions are needed. The objective of 
present study is to demonstrate the use of available data 
and geographic information systems to (1) examine geo-
graphic disparities in late stage breast cancer incidence, 
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(2) identify factors that are associated with higher rates 
of late stage breast cancer across different geographic 
areas, and (3) highlight areas that might benefit from 
targeted interventions. It is hoped that the approach 
offered in this work will be utilized broadly and outside 
of US, where cancer registry systems and technolo-
gies offer the same opportunity to identify places that 
require specific cancer control interventions to reduce 
cancer burden.
Late stage breast cancer (LSBC): theoretical foundation
Many factors contribute to LSBC at diagnosis. Among 
the major factors are the underlying biological aggres-
siveness of the disease [2]; demographic and socio-eco-
nomic characteristics [3–6], health insurance status [7, 
8], accessibility to healthcare and diagnostic services [9–
11], the availability and utilization screening tests [12].
Studies suggest that black women are more often diag-
nosed with LSBC than white women [13–15]. Furthermore, 
African-American/Black women are more likely than other 
US race and ethnic groups to develop aggressive breast 
cancer that is estrogen and progesterone receptor negative 
for negative for human epidermal growth factor and with 
distant metastases at diagnosis [16]. Evidence of ethnic dis-
parities suggests that Hispanic women experienced lower 
incidence rates of LSBC than non-Hispanic women [17].
Financial resources have been associated with breast 
cancer stage. Low socioeconomic status and poverty 
have been correlated with higher rates of late-stage 
breast cancer [5, 18, 19]. Other research evidence sug-
gests that poor literacy limits patients’ understanding of 
cancer screening and of symptoms of cancer, potentially 
adversely affecting their stage at diagnosis [20].
In studies that examined health insurance, having 
no insurance or Medicaid coverage is associated with a 
higher proportion of LSBC [8, 21]. Kuzmiak [8] found 
that, compared to insured patients, uninsured patients 
had a 66 % higher likelihood of presenting with LSBC.
Furthermore, it has been suggested that accessibility to 
health care, measured by lower availability of mammog-
raphy facilities, and/or primary care physicians—delays 
the detection of early stage breast cancer [10, 22–25].
Other evidence suggest that a lower density of mam-
mography facilities has been associated with the higher 
proportion of late stage breast cancer at diagnoses in 
rural areas [9] where there is more limited access to 
mammography facilities [25] and women are less likely 
to have received a mammogram [26]. Conversely, some 
studies found that geographical access to mammography 
facilities and primary care providers were not correlated 
with stage at diagnosis [27]. McLafferty [28, 29] found an 
“urban disadvantage”—higher proportions of late stage 
breast cancer in urban areas.
Many of the aforementioned contributors to LSBC are 
correlated with each other, change over time, and vary 
across geographical areas [13, 18, 20, 21]. Some factors 
such as the availability, cost, and accessibility of mam-
mography screening and diagnostic services are poten-
tially modifiable and addressing them could result in 
more women being diagnosed earlier when the disease is 
more amenable to treatment.
The aforementioned evidence of the major contributors 
to LSBC served as the theoretical foundation for selec-
tion of particular variables in our study. The next section 
provides an overview of these variables and data sources.
Methods
Data and variables
Data from the Surveillance, Epidemiology, and End 
Results (SEER) Program of the United States National 
Cancer Institute [30] were used as a source of outcome 
(dependent) variable in the analysis—late stage breast 
cancer incidence. SEER is comprised of 18 population-
based cancer registries covering 28 % of total US popula-
tion. The information collected includes primary tumor 
site, tumor morphology and stage at diagnosis, first 
course of treatment, and follow-up for patient’s vital sta-
tus. SEER provides baseline measures of cancer incidence 
rates, survival and prevalence statistics, and change in 
incidence and survival trends over time for several geo-
graphic units, listed in order from the smallest to the 
largest: County, Health Service Area, State, and Nation, 
and makes public use files available to support popula-
tion-based cancer research.
This study utilized SEER data on patients who were 
diagnosed with LSBC in the following eight states that 
comprise 26 % of the US population: California, Georgia, 
Iowa, Louisiana, Kentucky, New Jersey, New Mexico, and 
Utah. Cases of LSBC were defined as female, age 40 years 
or older, diagnosed with LSBC between 2006 and 2010. 
Late stage was defined as stage III and stage IV, using the 
guidelines from AJCC (American Joint Commission on 
Cancer) 6th Edition Cancer Staging Handbook [31].
In this study, the outcome variable is age-adjusted 
incidence rates of late stage breast cancer (LSBC) for 
females, 40  years of age and older, that were diagnosed 
in the period between 2006 and 2010 (the rates were age-
adjusted to 19 age groups using the 2000 US standard 
population).
The independent variables in the analysis represent 
some of the major factors that were found to contribute 
to LSBC including: socio-demographic and economic 
characteristics (race, ethnicity, literacy, education, 
median income, health insurance coverage); accessibil-
ity to health care (urban–rural residence); availability of 
screening services (density of obstetrics and gynecology 
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physicians and FDA approved mammography facilities) 
and utilization of mammography (percentage of women 
who utilized mammogram). The variables tested in the 
model with a detailed definition, data sources, and data 
timeline are shown in Table 1.
The socio-demographic data were obtained from the 
US Census Bureau 2010 data file, and include the follow-
ing variables: percentage of Black population; median 
household income, English literacy, education, health 
insurance coverage, and rural–urban residence.
Data on the number of OBGYN specialists in defined 
geographic areas was obtained from the Health Resources 
and Services Administration (HRSA) area resources file 
(ARF) [34]—estimates for the year 2010. These data were 
normalized by the total population to calculate a measure 
of OBGYN specialists per person.
The number of FDA approved mammography facili-
ties was available from the US Food and Drug Admin-
istration (FDA)—estimates for the year 2010. These 
data were normalized by the total population in order 
to generate density measure of the number of facilities 
per person.
Breast cancer screening measures were available 
from the small area estimates (SAE) file [33]. These are 
model-based, bias-corrected measures of the percent-
age of female population ages 40 and older who reported 
having a mammography test in the past 2  years—esti-
mates for the period 2000–2003.
Geographic unit of analysis
Data for all variables in this analysis were initially 
assigned to a county, the largest administrative unit in 
the United States. However, since the LSBC data are 
too sparse to provide stable 5-year incidence rates at the 
county level, the data were aggregated into health service 
areas (HSA’s) in order to assure stability of rates. HSA’s 
were originally defined by the National Center for Health 
Statistics as larger geographic areas comprised of one or 
more counties and are defined such that most residents 
in the region obtain hospital care from the same set of 
hospitals [32]. The original HSAs were modified by The 
National Cancer Institute so that any HSA that crossed 
state or SEER Registry boundaries were split and all 
counties from one HSA were in one state and/or SEER 
Registry. There are 944 HSAs in the US that contain 
3141 counties according to the modified HSA definition. 
Since the modified HSAs are delineated using geopoliti-
cal boundaries of counties and states, this makes them 
Table 1 Variables and data sources
Variables Definition Data sources
Dependent variables
 Late stage breast cancer diagnosis ages  
40 and above
Age-adjusted incidence rates of late stage breast 
cancer in females, ages 40 and above, per 
100,000 women diagnosed from 2006 to 2010
SEER http://www.seer.cancer.gov/data
Predictor variables
 Density of mammography facilities  
per person
Number of FDA approved mammography facilities 




 % Screening Percent of females, ages 40 and above that had 
mammography in the past 2 years; estimates for 
the period 2000–2003
Small Area Estimates (SAE) sae.cancer.gov
 Density of obstetrics and gynecology spe-
cialists per person
Number of OBGYN specialists in 2010, normalized 
by the total population in 2010
HRSA Area Resource File (ARF) http://arf.hrsa.gov/
 % Urban households Percent urban households (including urbanized 
areas and clusters) in 2010
US Census Bureau2010 http://www.census.
gov/2010census/
 % Black Percent of total population that is Black in 2010 US Census Bureau 2010 http://www.census.
gov/2010census/
 Median household income Median household Income in 2010 US Census Bureau 2010 http://www.census.
gov/2010census/
 % English litreracy Percentage of population 5 years and older that 
speaks English “very well” in 2010
US Census Bureau 2010 http://www.census.
gov/2010census/
 % With college degree Percent of total population with a Bachelor’s 
degree or higher in 2010
US Census Bureau 2010 http://www.census.
gov/2010census/
 % With private insurance Percent of female population, ages 40+ with 
private insurance only in 2010
US Census Bureau 2010 http://www.census.
gov/2010census/
 % Uninsured Percent of female population, ages 40+ with no 
health insurance coverage in 2010
US Census Bureau 2010 http://www.census.
gov/2010census/
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compatible with many data systems (e.g. census data), 
thus increasing the possibilities for data analysis [32].
Analysis
All statistical analyses were performed in SPSS 16.0 soft-
ware. We plotted the mean rates of late stage breast can-
cer by SEER state with confidence intervals; subsequently 
we ran Analysis of Variance (ANOVA) with Bonferroni 
adjustment to test whether or not the observed varia-
tions in the mean rates of LSBC were statistically signifi-
cant between the states (p < 0.05), and if so, which states 
differ significantly. Secondly, we classified the HSA-level 
incidence rates of LSBC for all eight SEER states using 
tertiles and computed the proportion of HSAs in each 
class by state. In addition we generated a map of inci-
dence rates of LSBC to show the location of HSAs with 
high, medium, or low rates across the eight SEER states. 
In the next step, we ran the “backward” stepwise linear 
regression to determine the factors that best explain 
LSBC incidence for females, ages 40 and older. Our anal-
ysis included the ten potential predictor variables listed 
in Table 1 and individual states as covariates. Backward 
stepwise regression essentially does multiple regression 
a number of times, each time removing the weakest cor-
related variable. The final model contains variables that 
best explain the variation in the dependent variable. 
Finally, we mapped the strongest predictors of LSBC by 
HSA of each SEER state in order to examine their geo-
graphic distributions and identify areas that may be in 
need of intervention. All maps were created using ESRI 
(Environmental Systems Research Institute, Inc. Red-
lands, CA) ArcGIS 10.1 software.
Results
Figures  1 and 2 illustrates the variation in the mean 
rates of LSBC for women 40  years of age and older, by 
state. The mean for eight SEER states is 46.3 per 100,000 
women. Ranked in order from highest to lowest state, 
New Jersey has, on an average, the highest incidence rates 
of LSBC (48.2 per 100,000 women), followed by Georgia, 
Kentucky, Louisiana, California, Utah, Iowa, and New 
Mexico with the lowest (33.6 per 100,000).
To test for significant differences in late stage breast 
cancer incidence among the eight states, we run an analy-
sis of variance and get an F statistic value of 4.241, with 
p  <  0.0001, which indicates that the variation in mean 
rates of LSBC by state is statistically significant. The 
results of Bonferoni test (Table 2) reveal where the signif-
icant differences lie: New Mexico has, on an average, sig-
nificantly lower incidence rates of LSBC than New Jersey 
(p < 0.0001), Georgia (p < 0.0001), Kentucky (p < 0.0001), 
and California (p < 0.003). There are no significant differ-
ences in mean rates of LSBC between other states.
Figure 2 represents a map of LSBC incidence by HSA. 
Incidence rates are classified into tertiles (low, medium, 
and high values) and percent contribution of HSAs to 
each class of values is summarized in Table  3: the state 
with the highest mean (48.2 per 100,000 women)—New 
Fig. 1 Mean rates and confidence intervals of LSBC incidence, females, Ages 40 and above, 2006–2010
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Jersey, has 70  % of HSAs with high incidence rates of 
LSBC (>46.0 per 100,000 women), and the remain-
ing 30  % with medium rates (40.1–46.0). In contrast, 
New Mexico—the state with the lowest mean (33.5) has 
80 % of HSAs with low rates (16.0–40.0) and 20 % with 
medium rates. In California, most of the HSAs (60  %) 
have medium rates. Georgia, Kentucky, and Louisiana 
each have greater proportion of HSAs in the medium and 
high range, respectively, while Utah and Iowa have pro-
portionately more HSAs in low and medium ranges.
Table  4 shows the descriptive statistics for variables 
that were entered into a stepwise regression, while 
Fig. 2 LSBC incidence by HSA, females, ages 40 and above, 2006–2010
Table 2 States that have significantly different LSBC incidence rates














Late stage breast 
cancer incidence, 
females ages 40 
and above
NM (33.5) NJ (48.2) −14.7* 2.1781 0.000 −22.057 −7.327
GA (47.6) −14.1* 2.4642 0.000 −21.996 −6.107
KY (45.9) 112.4* 2.4045 0.000 −20.245 −4.623
CA (43.6) −10.1* 2.2174 0.003 −17.420 −2.778
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Table 5 reveals which of those variables best explain the 
variation in LSBC incidence. The hypothesis being tested 
is: there is no association between late stage breast can-
cer and each of the predictors, assuming other predictors 
are associated with LSBC. We rejected the null hypoth-
esis based on the following results: model R  =  0.493 
and adjusted R2: 0.205, indicating that about 20  % of 
the total variance in LSBC incidence rates is explained 
by the regression model. The standardized coefficient 
shows that mammography density is the most strongly 
associated predictor of LSBC with a negative effect. On 
average, for each unit increase in Mammography density, 
the LSBC incidence rate decreases by 0.383.
Other HSA-level factors that explain the variation in 
LSBC across the eight SEER States include: percent of 
population with college degree or higher, English literacy 
(both significantly negatively associated with LSBC inci-
dence), and percent of Black population (significantly 
positively associated with LSBC). After considering these 
four predictors, the states of New Jersey, California, and 
Kentucky still have significantly higher rates of LSBC 
than New Mexico (the reference category).
The maps illustrate geographic disparities in: Density of 
FDA approved mammography facilities (Fig. 3), popula-
tion with BA degree or higher (Fig.  4) and Black popu-
lation (Fig.  5)—the three strongest predictors of LSBC 
found in this study. More importantly, the maps highlight 
where to focus targeted interventions. Our model sug-
gests that areas with low density of mammography, low 
educational attainment, and high percentage of Black 
population tend to have higher incidence rates of late 
stage breast cancer. In the first map (Fig. 3), red-shaded 
areas represent HSAs with high incidence rates of LSBC 
(>46.0 per 100,000) and, at the same time, with less than 
3 FDA approved mammography facilities per person. In 
the second map (Fig.  4), shaded areas highlight HSAs 
with high incidence rates of LSBC and, at the same time, 
relatively low educational attainment (less than 10  % of 
population having BA degree or higher). The last map 
(Fig. 5) highlights the areas where both the incidence of 
LSBC and proportion of Black population are high.
Conclusions
In this study we sought to describe the geographic dis-
parities in late stage breast cancer incidence across eight 
states in the US and identify areas where LSBC are com-
mon, and where further research could help better iden-
tify reasons for the high incidence of late stage diagnoses 
and interventions could be used to modify factors con-
tributing to the high rates of LSBC. For example, iden-
tification of areas with higher rates of LSBC and factors 
contributing to them may help identify where resources 
might be needed to increase screening for breast cancer 
and provide greater availability of services that can pro-
vide more aggressive treatments.
We found heterogeneity across the eight states exam-
ined in the incidence of late stage diagnosis, with the 
state with the highest percent, New Jersey at 48 per 
100,000 women, having an incidence rate 30  % higher 
than that of the lowest, New Mexico, where the rate was 
33.5 per 100,000 women. Our results indicate that New 
Mexico has significantly lower incidence rates of LSBC 
than four other states.
Table 3 Percentage of  HSAs with  low, medium, or high 
rates of LSBC by SEER state





New Jersey 0 30 70
Georgia 20 40 40
Kentucky 20 30 50
Louisiana 30 20 50
California 30 60 20
Utah 40 40 20
Iowa 45 20 25
New Mexico 80 20 0
Table 4 Descriptive statistics for  variables entered in  the 
regression analysis
Variables Mean Range
Late stage breast cancer diagnosis ages 40 and 
above—dependent variable
43.81 62.90
Density of mammography facilities per person 3.99 14.22
% Screening 0.66 0.32
Density of obstetrics and gynecology specialists per 
person
7.70 25.44
% Urban households 0.56 1.00
% Black 0.12 0.61
Median household income 46205 68985
% English literacy 5.14 26.68
% With college degree 0.10 0.41
% With private insurance 0.49 0.45
% Uninsured 0.11 0.40
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We also found that lower density of screening mam-
mography units within HSAs were associated with 
higher rates of late stage breast cancer in our sample. 
This is consistent with prior findings regarding lack 
of accessibility to health care—whether measured by 
lower availability of mammography facilities and pri-
mary care physicians—delays the detection of early 
stage breast cancer [10, 11, 22–25]. Other studies 
Table 5 Best model fit: effects of state, demographic, and health characteristics on LSBC incidence rates





B Std. error Beta
(Constant) 48.871 2.970 16.456 0.000
Density of mammography facilities per 
person
−0.541 0.156 −0.383 −3.457 0.001
% With college degree −36.433 13.964 −0.243 −2.609 0.010
% Black 13.879 4.993 0.239 2.779 0.006
% English literacy −0.836 0.406 −0.174 −2.058 0.041
New Jersey 10.069 2.786 0.289 3.614 0.000
California 9.105 2.320 0.428 3.924 0.000
Kentucky 4.039 1.984 0.179 2.035 0.044
Fig. 3 Number of FDA approved mammography facilities per person by HSA
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suggest that a lower density of mammography facilities 
units has been associated with the higher proportion of 
late stage breast cancer at diagnoses in rural areas [9] 
where there is more limited access to mammography 
facilities [26] and women are less likely to have received 
a mammogram [27]. Our population-based sample cov-
ered all parts of the states studied, and so included both 
urban areas as well as rural areas. In our study, how-
ever, the percentage of the HSA’s population that was 
urban did not contribute to late stage breast cancer 
rates.
McLafferty [28, 29] found an “urban disadvantage”—
higher proportions of late stage breast cancer in urban 
areas. The driving factor of late stage breast cancer may 
be limited use of mammography facilities whether the 
barrier is access and distance or demographic and socio-
economically based. Again, our study does not support 
nor contradict these findings, given that the urban–rural 
factor was not significant predictor of late stage.
Financial resources have been associated with breast 
cancer stage. For example, low socioeconomic status 
and poverty have been correlated with higher rates of 
late-stage breast cancer [5, 18, 19]. In the current study 
the percentage of people within an HSA who had a col-
lege education was inversely associated with rates of 
late stage breast cancer across the eight states. A col-
lege education is likely a surrogate for a higher income 
as well as higher educational attainment. In addition, 
it has been suggested that poor literacy limits patients’ 
understanding of cancer screening and of symptoms 
of cancer, potentially adversely affecting their stage at 
diagnosis [20]. In our study, poor English literacy was 
significantly associated with higher rates of late stage 
breast cancer.
In studies that examined health insurance, having 
no insurance or Medicaid coverage is associated with a 
higher proportion of LSBC [8, 21]. In the current study 
an increased percentage of people within HSAs who had 
Fig. 4 Percent of population with BA degree or higher by HSA
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private health insurance did not contribute to late stage 
breast cancer rates.
The US cancer registry systems and available data 
and mapping technology can provide detailed infor-
mation about late stage breast cancer by geographical 
regions, offering valuable opportunities to identify can-
cer-related health disparities and areas where further 
investigation and interventions are needed. We mapped 
and highlighted Health Service Areas that have any com-
bination of high late stage breast cancer incidence and 
significantly associated factors; the obvious motivation 
was to identify areas that might benefit from targeted 
interventions.
Further work, however is needed in order to capture 
additional factors that drive the differences in LSBC inci-
dence among states, and that did not come as significant 
in our model. Identifying underlying reasons for geo-
graphic variation presents many challenges, including 
missing data and measurement issues. In addition, some 
area level data is collected and released for research in 
varying time periods; this is a limitation of our study 
where there is a substantial variation in timeline of 
some data; this could have affected our results if there 
were secular trends over time for specific predictors or 
LSBC. In addition, factors available at the geographical 
level are often imprecise or do not fully capture impor-
tant underlying domains. For example, the density of 
obstetricians and gynecologists, used as an indicator of 
one type of physician who commonly refers women for 
mammographic screening; or the density of mammo-
graphic facilities as a proxy for the capacity of the geo-
graphic area to provide mammograms to the population 
of women are inherently limited. Nevertheless reducing 
cancer-related geographic disparities is an important 
goal.
Strengths of the study included population-based 
cancer registries that capture almost 100  % of all can-
cers in defined geographic areas, well-documented and 
Fig. 5 Percent of black population by HSA
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standardized methods across states for categorizing data 
from registries into stage, coverage of roughly 28 % of the 
US population, and the opportunity to compare late stage 
rates across states in contrast to most earlier research 
studies, which focused on smaller geographic units. Geo-
spatial analysis of patterns of late stage breast cancer can 
be useful to inform targeted interventions in the areas 
that need them the most.
In conclusion, this study suggests that in the eight US 
states examined, higher rates of late stage breast cancer 
are more common in areas with predominantly black 
population (disparity in race), where English literacy, per-
centage of population with college degree (disparity in 
socio-demographic characteristics) and screening avail-
ability are low. The approach described in this work may 
be utilized both within and outside US, wherever cancer 
registry systems and area-level potential predictor vari-
ables and mapping technologies are available to identify 
and better characterize areas with high risks of cancer 
or cancer-related outcomes that may benefit from fur-
ther investigation and interventions to reduce the cancer 
burden.
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